Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183183 · ClinicalTrials.gov registry record · Phase 3
Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room
A Phase 3 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,137
- Enrollment target
NCT00183183: Completed Phase 3 study, sponsored by UConn Health.
NCT00183183 is a Phase 3 study that has completed, run by UConn Health. The registered enrollment target is 1,137 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183183, a Phase 3 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,137 participants
- Enrollment target
Study Summary
Alcohol abuse is associated with injury, chronic illness, absenteeism from work, and social costs to families and communities. The goal of this project is to translate motivational interventions successful in the primary care setting to the Emergency Department (ED) environment by implementing screening, brief intervention and referral to treatment (SBIRT) in order to reduce at-risk drinking among ED patients.
Interventions
- BEHAVIORAL Screening and Brief Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,137 participants |
| Start Date | 2004-04 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
What the finished NCT00183183 record still lists
NCT00183183 is an interventional study that assigns participants to a tested intervention. Its 1,137 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 1 intervention - of which Screening and Brief Intervention is the first listed.
NCT00183183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00183183 about?
NCT00183183 is a clinical study titled "Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room". Alcohol abuse is associated with injury, chronic illness, absenteeism from work, and social costs to families and communities. The goal of this project is to translate motivational interventions successful in the primary care setting to the Emergency Department (ED) environment by implementing scree...
What is the current status of trial NCT00183183?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,137 participants. The study started on 2004-04. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00183183?
The interventions under investigation include: Screening and Brief Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183183?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00183183's enrollment target sits among peer trials
1,137 243rd of 2000 higher than 1,758 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia